Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like Study confirms no causal link between COVID-19 and ischemic priapism June 12, 2024 Study shines new light on how harmful industries shape scientific narratives July 12, 2025 Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors January 30, 2025